Movement Alert｜Twist Bioscience Corp Falls 5.01% in Regular Trading, Insider Selling and Profit-Taking Weigh on Shares After Anthropic Rally

Market Focus09-02 02:48

On September 2, Twist Bioscience Corp fell 5.01% in regular trading, trading at $132.12 per share, with turnover of $106 million. The stock has pulled back sharply from recent highs near $155, extending a multi-session decline amid notable insider selling activity.

Multiple Form 144 filings for proposed securities sales were disclosed in late August, including a holding change statement by CEO Emily Leproust filed on August 28. The selling pressure follows a roughly 17% single-day surge on August 20, when the company announced its selection by Anthropic as an independent evaluator for a multi-arm AI-driven protein design project. In addition, the company had previously filed a shelf registration in June for the potential sale of up to $200 million in common stock under an at-the-market program, compounding dilution concerns.

Within the Biotechnology sector, the broader industry showed gains on the session, with Moderna up 6.65%, Gilead Sciences up 1.74%, AbbVie up 1.53%, Amgen up 1.50%, and bioAffinity Technologies up 44.96%, contrasting with Twist Bioscience Corp's decline.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1116638166?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-02 02:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116638166","market":"us","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Corp Falls 5.01% in Regular Trading, Insider Selling and Profit-Taking Weigh on Shares After Anthropic Rally","media":"Market Focus","content":"<p><p>On September 2, Twist Bioscience Corp fell 5.01% in regular trading, trading at $132.12 per share, with turnover of $106 million. The stock has pulled back sharply from recent highs near $155, extending a multi-session decline amid notable insider selling activity.</p><p>Multiple Form 144 filings for proposed securities sales were disclosed in late August, including a holding change statement by CEO Emily Leproust filed on August 28. The selling pressure follows a roughly 17% single-day surge on August 20, when the company announced its selection by Anthropic as an independent evaluator for a multi-arm AI-driven protein design project. In addition, the company had previously filed a shelf registration in June for the potential sale of up to $200 million in common stock under an at-the-market program, compounding dilution concerns.</p><p>Within the Biotechnology sector, the broader industry showed gains on the session, with Moderna up 6.65%, Gilead Sciences up 1.74%, AbbVie up 1.53%, Amgen up 1.50%, and bioAffinity Technologies up 44.96%, contrasting with Twist Bioscience Corp's decline.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Corp Falls 5.01% in Regular Trading, Insider Selling and Profit-Taking Weigh on Shares After Anthropic Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Corp Falls 5.01% in Regular Trading, Insider Selling and Profit-Taking Weigh on Shares After Anthropic Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-02 02:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 2, Twist Bioscience Corp fell 5.01% in regular trading, trading at $132.12 per share, with turnover of $106 million. The stock has pulled back sharply from recent highs near $155, extending a multi-session decline amid notable insider selling activity.</p><p>Multiple Form 144 filings for proposed securities sales were disclosed in late August, including a holding change statement by CEO Emily Leproust filed on August 28. The selling pressure follows a roughly 17% single-day surge on August 20, when the company announced its selection by Anthropic as an independent evaluator for a multi-arm AI-driven protein design project. In addition, the company had previously filed a shelf registration in June for the potential sale of up to $200 million in common stock under an at-the-market program, compounding dilution concerns.</p><p>Within the Biotechnology sector, the broader industry showed gains on the session, with Moderna up 6.65%, Gilead Sciences up 1.74%, AbbVie up 1.53%, Amgen up 1.50%, and bioAffinity Technologies up 44.96%, contrasting with Twist Bioscience Corp's decline.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1116638166","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116638166","pubTimestamp":1788288495,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 2, Twist Bioscience Corp fell 5.01% in regular trading, trading at $132.12 per share, with turnover of $106 million. The stock has pulled back sharply from recent highs near $155,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"走势警报|Twist Bioscience Corp 在人为反弹后常规交易中下跌 5.01%，内幕抛售和获利了结给股价带来压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On September 2, Twist Bioscience Corp fell 5.01% in regular trading, trading at $132.12 per share, with turnover of $106 million. The stock has pulled back sharply from recent highs near $155, extending a multi-session decline amid notable insider selling activity.Multiple Form 144 filings for proposed securities sales were disclosed in late August, including a holding change statement by CEO Emily Leproust filed on August 28. The selling pressure follows a roughly 17% single-day surge on August 20, when the company announced its selection by Anthropic as an independent evaluator for a multi-arm AI-driven protein design project. In addition, the company had previously filed a shelf registration in June for the potential sale of up to $200 million in common stock under an at-the-market program, compounding dilution concerns.Within the Biotechnology sector, the broader industry showed gains on the session, with Moderna up 6.65%, Gilead Sciences up 1.74%, AbbVie up 1.53%, Amgen up 1.50%, and bioAffinity Technologies up 44.96%, contrasting with Twist Bioscience Corp's decline.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1116638166","isCrawlerRequest":true}